Morgan Stanley Maintains Equal-Weight on Gilead Sciences, Raises Price Target to $65

Morgan Stanley analyst Matthew Harrison maintains Gilead Sciences (NASDAQ:GILD) with a Equal-Weight and raises the price target from $63 to $65.

Morgan Stanley analyst Matthew Harrison maintains Gilead Sciences (NASDAQ:GILD) with a Equal-Weight and raises the price target from $63 to $65.

Total
0
Shares
Related Posts